Relapsed CLL
Oncology·MeSH: Lymphoma, Non-Hodgkin
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
Frequently asked questions
How many drugs are in development for Relapsed CLL?
BioSniper tracks 1 drug in development for Relapsed CLL across 1 company.
How many clinical trials target Relapsed CLL?
There are 1 clinical trial targeting Relapsed CLL tracked by BioSniper.
Analyze Nurix Therapeutics, Inc.'s Relapsed CLL pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company